Interventions to improve antibiotic prescribing in upper middle income countries: A systematic review of the literature 1990-2009

Macedonian Journal of Medical Sciences

Volumn 6, Issue 1, 2013, Pages 84-91

  Ivanovska, Verica ^a,b   Holloway, Kathleen Anne ^c  

^a UTRECHT UNIVERSITY   (Netherlands)

^b GOCE DELCEV UNIVERSITY   (Macedonia)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Antibiotics; Appropriate use; Indicators; Interventions; Medical doctors; Prescribing practices; Primary health care; Systematic review; Upper middle income countries

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; DRUG USE; HEALTH ECONOMICS; HEALTH EDUCATION; HUMAN; INCOME; PHYSICIAN; PNEUMONIA; PRESCRIPTION; PRIMARY HEALTH CARE; PUBLIC HEALTH PROBLEM; REVIEW; SYSTEMATIC REVIEW; VIRAL UPPER RESPIRATORY TRACT INFECTION;

EID: 84875324832     PISSN: 18575749     EISSN: 18575773     Source Type: Journal    
DOI: 10.3889/MJMS.1857-5773.2012.0268     Document Type: Review

References (48)

1. European Centre for Disease Prevention and Control. Antimicrobial resistance. European Centre for Disease Prevention and Control, 2011. www.ecdc.europa.eu/en/ healthtopics/antimicrobial_resistance/Pages/index.aspx. Accessed on 28 November 2011.
2. rd Edition, Geneva 2011. http://apps.who.int/ medicinedocs/documents/s18064en/s18064en.pdf.
3. World Health Organization. Medicines use in primary care in developing and transitional countries: Fact book summarizing results from studies reported between 1990 and 2006. World Health Organization, Geneva, 2009. http:// www.who.int/medicines/publications/primary_care_8April09.pdf.
4. De Melker RA, Kuyvenhoven MM. Management of upper respiratory tract infections in Dutch family practice. J Fam Pract. 1994;38:353-357.
5. McCaig LF, Besser RE, Hughes JM. Antimicrobial drug prescription in ambulatory care settings, United States, 1992- 2000 [Published correction appears in Emerg Infect Dis 2003;9:609]. Emerg Infect Dis. 2003;9:432-437.
6. Arroll B, Kenealy T. Antibiotics for the common cold. Cochrane Database Syst Rev. 2000;(2):CD000247.
7. Del Mar CB, Glasziou PP, Spinks AB. Antibiotics for sore throat. Cochrane Database Syst Rev. 2000;(4):CD000023.
8. Becker L, Glazier R, McIsaac W, Smucny J. Antibiotics for acute bronchitis. Cochrane Database Syst Rev 2000;(2):CD000245.
9. Glasziou PP, Del Mar CB, Sanders SL, Hayem M Antibiotics for acute otitis media in children. Cochrane Database Syst Rev. 2004;(1):CD000219.
10. Williams JW, Aguilar C, Makela M, Cornell J, Hollman DR, Chiquette E, et al. Antibiotics for acute maxillary sinusitis. Cochrane Database Syst Rev. 2003;(2):CD000243.
11. Goossens H, Ferech M, Vander Stichele R, Elseviers M. ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005; 365: 579-587.
12. Van Roosmalen MS et al. Antibiotic prescribing in primary care: First choice and restrictive prescribing are two different traits. Qual Saf Health Care. 2007;16(2):105-109.
13. Arroll B, Kenealy T. Antibiotics for the common cold. Cochrane Database Syst Rev. 2000;(2):CD000247
14. Mainous AG 3rd, Hueston WJ. The cost of antibiotics in treating upper respiratory tract infections in a Medicaid population. Arch Fam Med. 1998; 7: 45-49
15. Goossens H. Antibiotic consumption and link to resistance. Clin Microbiol Infect. 2009;15(Suppl. 3):S12-S15.
16. World Health Organization. WHO Antimicrobial resistance. Fact sheet N°194 February 2011. World Health Organization, Geneva, 2011. www.who.int/mediacentre/factsheets/fs194/en/
17. Kaplan W, Laing R. Priority medicines for Europe and the world. World Health Organization, Geneva, 2004. http:// hinfo.humaninfo.ro/gsdldata/collect/medicinedocs/index/ assoc/s14208e/s14208e.pdf.
18. Goossens H et al. European Surveillance of Antimicrobial Consumption Project Group. Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries. Clin Infect Dis 2007, 44:1091-1095.
19. Jelinski S, Parfrey P, Hutchinson J. Antibiotic utilisation in community practices: guideline concurrence and prescription necessity. Pharmacoepidemiol Drug Saf 2005; 14: 319-26.
20. World Health Organization. World Health Assembly Resolution 58.27. Improving the containment of antimicrobial resistance. World Health Organization, Geneva, 2005. http:// apps.who.int/gb/ebwha/pdf_files/WHA58/WHA58_27-en.pdf.
21. World Health Organization. World Health Assembly Resolution 60.16. Progress in the rational use of medicine. World Health Organization, Geneva, 2007. http://apps.who.int/ gb/ebwha/pdf_files/WHA60/A60_R16-en.pdf.
22. World Health Organization. WHO Global Strategy for Containment of Antimicrobial Resistance. World Health Organization, Geneva, 2001. www.who.int/drugresistance/ WHO_Global_Strategy_English.pdf.
23. European Commission. Action plan against the rising threats from Antimicrobial Resistance. European Commission, Brussels, 2011. http://ec.europa.eu/dgs/health_consumer/ docs/communication_amr_2011_748_en.pdf.
24. Centers for Disease Control and Prevention. Treatment Guidelines for Upper Respiratory Tract Infections. Centers for Disease Control and Prevention 2006. www.aafp.org/afp/2006/ 0915/p956.pdf.
25. National Health Service, UK. Respiratory tract infections - antibiotic prescribing. National Institute for Health and Clinical Excellence. NHS 2008. www.nice.org.uk/nicemedia/pdf/ CG69FullGuideline.pdf.
26. World Health Organization. Acute Respiratory Infections (ARI). Case Management Charts. World Health Organization, Geneva, 1991.
27. World Health Organization. A Manual for the Treatment of Diarrhoea. World Health Organization, Geneva, 1990.
28. World Health Organization. Promoting rational use of medicines: core components. WHO Policy Perspectives of Medicines, no. 5. World Health Organization, Geneva, 2002.
29. Holloway KA. Combating Inappropriate Use of Medicines. Expert Rev Clin Pharmacol. 2011;4(3):335-348.
30. World Health Organization. Medicines: rational use of medicines. Fact sheet N°338, World Health Organization, Geneva, 2010. www.who.int/mediacentre/factsheets/fs338/en/ index.html.
31. Belongia EA, Schwartz B. Strategies for promoting judicious use of antibiotics by doctors and patients. BMJ. 1998;317:668-71.
32. Arnold SR, Evans M, Straus SE. Interventions to improve antibiotic prescribing practices in ambulatory care (Protocol for a Cochrane Review). Cochrane Library; Issue 1, 2003. Oxford: Update Software.
33. Gross PA, Pujat D. Implementing practice guidelines for appropriate antimicrobial usage. A systematic review. Med Care. 2001;39:II55-II69.
34. Welschen I, Kuyvenhoven MM, Hoes AW, et al. Effectiveness of a multiple intervention to reduce antibiotic prescribing for respiratory tract symptoms in primary care: randomised controlled trial. BMJ. 2004; 21; 329 (7463):431.
35. World Health Organization. Interventions and strategies to improve the use of antimicrobials in developing countries. Drug Management Program. WHO/CDS/CSR/DRS/2001. World Health Organization, Geneva, 2001. www.who.int/csr/ resources/publications/drugresist/ WHO_CDS_CSR_DRS_2001_9/en/
36. World Bank. Country and Lending Groups. http:// data.worldbank.org/about/country-classifications/country-and-lending-groups#Upper_middle_income. Accessed on 26 November 2011.
37. International Network for the Rational Use of Drugs. INRUD Medicines Use bibliography. http://www1.inrud.org:81/ rmwp?&func=advSearch.
38. World Health Organization. How to investigate drug use in health facilities: Selected drug use indicators. (DAP Research Series N°7. WHO/DAP/93.1). World Health Organization, Geneva, 1993.
39. World Health Organization. Integrated Management of Childhood Illness. World Health Organization, Geneva, 1999. http://www.idpas.org/58relatedprograms1.html.
40. Yu-qin Wang, Lang Zhang, et al. Multi-centre indicator intervention research on rational drug use, Xuanwu Hospital Group and Centre for Drug Re-evaluation of State Drug Administration and Ministry of Health, Beijing, China, 2007.
41. Gonzalez Ochoa E, Armas Perez L, Bravo Gonzalez JR, Cabrales Escobar J, Rosales Corrales R, Abreu Suarez G. Prescription of antibiotics for mild acute respiratory infections in children. Bull Pan Am Health Org, 1996; 30:106-117.
42. Hermida J, Robalino ME. Increasing compliance with maternal and child care quality standards in Ecuador. Int J Qual Health Care. 2002;14(suppl 1): 25-34.
43. Esmaily HM, Silver I, Shiva S, Garjani A, et al., Can rational prescribing be improved by an outcome-based educational approach? A randomised trial completed in Iran; J Contin Educ Health Prof. 2010;30(1):11-18.
44. Mohagheghi MA, Mosavi-Jarrahi A, Khatemi-Moghaddam M, Afhami S, Khodai S, Azemoodeh O. Community-based outpatient practice of antibiotics use in Tehran. Pharmacoepidemiol Drug Saf. 2005;14: 135-138.
45. Garjani A, Salimnejad M, Shamsmohamadi M, Baghchevan V, Vahidi RG, Maleki-Dijaz N, Rezazadeh H. Effect of interactive group discussion among physicians to promote rational prescribing. East Mediterr Health J, 2009;15(2).
46. Teng CL et al. Modifying antibiotic prescribing: the effectiveness of academic detailing plus information leaflet in a Malaysian primary care setting. Med J Malaysia. 2006;61(3): 323-331.
47. Perez-Cuevas R, Guiscafre H, Munoz O, Reyes H, Tome P, Libreros V et al. Improving physician prescribing patterns to treat rhinopharyngitis. Intervention strategies in two health systems of Mexico. Soc Sci and Med. 1996; 42(8):1185-1194.
48. World Health Organization. The Former Yugoslav Republic of Macedonia Health system review on Health Systems and Policies. Health Systems in Transition 2006; 8(2):1-98. The European Observatory on Health Systems and Policies, World Health Organization, 2006.